Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19.
Khunti K, Ruan Y, Davies J, Field BCT, Harris S, Kosiborod M, Nagi D, Narendran P, Patel D, Ryder REJ, Várnai KA, Wild SH, Wilmot EG, Rea R; ABCD COVID-19 Diabetes National Audit Investigators. Khunti K, et al. Among authors: wild sh. Diabetes Care. 2022 Sep 8:dc220357. doi: 10.2337/dc22-0357. Online ahead of print. Diabetes Care. 2022. PMID: 36074663
Effect of socioeconomic status on mortality among people with type 2 diabetes: a study from the Scottish Diabetes Research Network Epidemiology Group.
Walker JJ, Livingstone SJ, Colhoun HM, Lindsay RS, McKnight JA, Morris AD, Petrie JR, Philip S, Sattar N, Wild SH; Scottish Diabetes Research Network Epidemiology Group. Walker JJ, et al. Among authors: wild sh. Diabetes Care. 2011 May;34(5):1127-32. doi: 10.2337/dc10-1862. Epub 2011 Mar 18. Diabetes Care. 2011. PMID: 21421800 Free PMC article.
Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group.
Govan L, Wu O, Briggs A, Colhoun HM, Fischbacher CM, Leese GP, McKnight JA, Philip S, Sattar N, Wild SH, Lindsay RS; Scottish Diabetes Research Network Epidemiology Group. Govan L, et al. Among authors: wild sh. Diabetes Care. 2011 Sep;34(9):1992-7. doi: 10.2337/dc10-2099. Epub 2011 Jul 25. Diabetes Care. 2011. PMID: 21788623 Free PMC article.
Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission.
Wild SH, Walker JJ, Morling JR, McAllister DA, Colhoun HM, Farran B, McGurnaghan S, McCrimmon R, Read SH, Sattar N, Byrne CD; Scottish Diabetes Research Network Epidemiology Group. Wild SH, et al. Diabetes Care. 2018 Feb;41(2):341-347. doi: 10.2337/dc17-1590. Epub 2017 Nov 22. Diabetes Care. 2018. PMID: 29167212
Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.
Read SH, van Diepen M, Colhoun HM, Halbesma N, Lindsay RS, McKnight JA, McAllister DA, Pearson ER, Petrie JR, Philip S, Sattar N, Woodward M, Wild SH; Scottish Diabetes Research Network Epidemiology Group. Read SH, et al. Among authors: wild sh. Diabetes Care. 2018 Sep;41(9):2010-2018. doi: 10.2337/dc18-0578. Epub 2018 Jul 12. Diabetes Care. 2018. PMID: 30002197 Free article.
Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland.
Caparrotta TM, Blackbourn LAK, McGurnaghan SJ, Chalmers J, Lindsay R, McCrimmon R, McKnight J, Wild S, Petrie JR, Philip S, McKeigue PM, Webb DJ, Sattar N, Colhoun HM; Scottish Diabetes Research Network–Epidemiology Group. Caparrotta TM, et al. Diabetes Care. 2020 Sep;43(9):2034-2041. doi: 10.2337/dc20-0120. Epub 2020 Jun 24. Diabetes Care. 2020. PMID: 32581068
Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies.
Caparrotta TM, Greenhalgh AM, Osinski K, Gifford RM, Moser S, Wild SH, Reynolds RM, Webb DJ, Colhoun HM. Caparrotta TM, et al. Among authors: wild sh. Diabetes Ther. 2021 Apr;12(4):991-1028. doi: 10.1007/s13300-021-01004-2. Epub 2021 Mar 4. Diabetes Ther. 2021. PMID: 33665777 Free PMC article. Review.
402 results